194 related articles for article (PubMed ID: 35224098)
1. A Three-mRNA Signature Associated with Pyrimidine Metabolism for Prognosis of BRCA.
Zhang X; Zhang Q; Xie X; Li Y; Pang Z; Yu T
Biomed Res Int; 2022; 2022():7201963. PubMed ID: 35224098
[TBL] [Abstract][Full Text] [Related]
2. An eight-lncRNA signature predicts survival of breast cancer patients: a comprehensive study based on weighted gene co-expression network analysis and competing endogenous RNA network.
Sun M; Wu D; Zhou K; Li H; Gong X; Wei Q; Du M; Lei P; Zha J; Zhu H; Gu X; Huang D
Breast Cancer Res Treat; 2019 May; 175(1):59-75. PubMed ID: 30715658
[TBL] [Abstract][Full Text] [Related]
3. A four-gene signature in the tumor microenvironment that significantly associates with the prognosis of patients with breast cancer.
Wang J; Yang Z; Zhang C; Ouyang J; Zhang G; Wu C
Gene; 2020 Nov; 761():145049. PubMed ID: 32791092
[TBL] [Abstract][Full Text] [Related]
4. Identification of Ten-Gene Related to Lipid Metabolism for Predicting Overall Survival of Breast Invasive Carcinoma.
Wang Z; Wang F
Contrast Media Mol Imaging; 2022; 2022():8348780. PubMed ID: 35919504
[TBL] [Abstract][Full Text] [Related]
5. A six-gene-based signature for breast cancer radiotherapy sensitivity estimation.
Chen X; Zheng J; Zhuo ML; Zhang A; You Z
Biosci Rep; 2020 Dec; 40(12):. PubMed ID: 33179733
[TBL] [Abstract][Full Text] [Related]
6. A Novel Signature Integrated of Immunoglobulin, Glycosylation and Anti-Viral Genes to Predict Prognosis for Breast Cancer.
Xu S; Liu Y; Ma H; Fang S; Wei S; Li X; Lu Z; Zheng Y; Liu T; Zhu X; Xu D; Pan Y
Front Genet; 2022; 13():834731. PubMed ID: 35432482
[No Abstract] [Full Text] [Related]
7. NR3C2-Related Transcriptome Profile and Clinical Outcome in Invasive Breast Carcinoma.
Lu J; Hu F; Zhou Y
Biomed Res Int; 2021; 2021():9025481. PubMed ID: 33564687
[TBL] [Abstract][Full Text] [Related]
8. A three-microRNA signature predicts clinical outcome in breast cancer patients.
Cheng D; He H; Liang B
Eur Rev Med Pharmacol Sci; 2018 Oct; 22(19):6386-6395. PubMed ID: 30338807
[TBL] [Abstract][Full Text] [Related]
9. Analysing a Novel RNA-Binding-Protein-Related Prognostic Signature Highly Expressed in Breast Cancer.
Lan Y; Su J; Xue Y; Zeng L; Cheng X; Zeng L
J Healthc Eng; 2021; 2021():9174055. PubMed ID: 34707800
[TBL] [Abstract][Full Text] [Related]
10. A ferroptosis-associated gene signature for the prediction of prognosis and therapeutic response in luminal-type breast carcinoma.
Peng Y; Yu H; Zhang Y; Qu F; Tang Z; Qu C; Tian J; Zong B; Wang Y; Ren H; Liu S
Sci Rep; 2021 Sep; 11(1):17610. PubMed ID: 34475496
[TBL] [Abstract][Full Text] [Related]
11. Exploration of prognostic genes and risk signature in breast cancer patients based on RNA binding proteins associated with ferroptosis.
Chen X; Yang C; Wang W; He X; Sun H; Lyu W; Zou K; Fang S; Dai Z; Dong H
Front Genet; 2023; 14():1025163. PubMed ID: 36911389
[No Abstract] [Full Text] [Related]
12. Identification and validation of a novel zinc finger protein-related gene-based prognostic model for breast cancer.
Ye M; Li L; Liu D; Wang Q; Zhang Y; Zhang J
PeerJ; 2021; 9():e12276. PubMed ID: 34721975
[TBL] [Abstract][Full Text] [Related]
13. An Integrative Model of miRNA and mRNA Expression Signature for Patients of Breast Invasive Carcinoma with Radiotherapy Prognosis.
Bing Z; Tian J; Zhang J; Li X; Wang X; Yang K
Cancer Biother Radiopharm; 2016 Sep; 31(7):253-60. PubMed ID: 27610468
[TBL] [Abstract][Full Text] [Related]
14. Prognosis stratification in breast cancer and characterization of immunosuppressive microenvironment through a pyrimidine metabolism-related signature.
Luo Y; Tian W; Lu X; Zhang C; Xie J; Deng X; Xie Y; Yang S; Du W; He R; Wei W
Front Immunol; 2022; 13():1056680. PubMed ID: 36524129
[TBL] [Abstract][Full Text] [Related]
15. Identification of a Liver Progenitor Cell-Related Genes Signature Predicting Overall Survival for Hepatocellular Carcinoma.
Li X; Lin J; Pan Y; Cui P; Xia J
Technol Cancer Res Treat; 2021; 20():15330338211041425. PubMed ID: 34866477
[No Abstract] [Full Text] [Related]
16. Comprehensive research into prognostic and immune signatures of transcription factor family in breast cancer.
Wu Q; Zheng S; Lin N; Xie X
BMC Med Genomics; 2023 Apr; 16(1):87. PubMed ID: 37098532
[TBL] [Abstract][Full Text] [Related]
17. Establishment and validation of a novel autophagy-related gene signature for patients with breast cancer.
Du JX; Chen C; Luo YH; Cai JL; Cai CZ; Xu J; Ni XJ; Zhu W
Gene; 2020 Dec; 762():144974. PubMed ID: 32707305
[TBL] [Abstract][Full Text] [Related]
18. Identification of the prognostic value of ferroptosis-related gene signature in breast cancer patients.
Wang D; Wei G; Ma J; Cheng S; Jia L; Song X; Zhang M; Ju M; Wang L; Zhao L; Xin S
BMC Cancer; 2021 May; 21(1):645. PubMed ID: 34059009
[TBL] [Abstract][Full Text] [Related]
19. Systematic analysis of lncRNA-miRNA-mRNA competing endogenous RNA network identifies four-lncRNA signature as a prognostic biomarker for breast cancer.
Fan CN; Ma L; Liu N
J Transl Med; 2018 Sep; 16(1):264. PubMed ID: 30261893
[TBL] [Abstract][Full Text] [Related]
20. A lymph node metastasis-related protein-coding genes combining with long noncoding RNA signature for breast cancer survival prediction.
Sui Y; Ju C; Shao B
J Cell Physiol; 2019 Nov; 234(11):20036-20045. PubMed ID: 30950057
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]